Echography Study_Anthropometric Measurements
Measurement of Skin-to-Muscle and Skin-to-Bone Distances in Adult and Pediatric Populations Before and While Applying a Force Similar to the ZENEO® Triggering Force
1 other identifier
interventional
90
1 country
1
Brief Summary
This is a multi-center, exploratory, estimation study in both adult and pediatric populations. There is no investigational product injection during this study The exploratory objective of this study is to evaluate the anatomical characteristics of both anterolateral thighs in healthy adult and healthy pediatric populations (2 to 17 years old) by ultrasound scan before and while applying a force similar to the ZENEO® triggering force. In the healthy adult population, anatomical characteristics of one shoulder (deltoid) and one upper arm (biceps and triceps) will also be evaluated by ultrasound scan before and while applying a force similar to ZENEO® triggering force. Only ultrasound procedures will be performed using an investigational ultrasound system. All subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility assessment and the ultrasound scans will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2024
CompletedStudy Start
First participant enrolled
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJuly 22, 2024
July 1, 2024
7 months
January 31, 2024
July 19, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
STBD : Skin To Bone Distance
Distance measurement
Day1
STMD: Skin To Muscle Distance
Distance measurement
Day1
Thickness of skin layers (dermis, hypodermis)
Thickness measurement
Day1
Thickness of muscle layers
Thickness measurement
Day1
Secondary Outcomes (1)
Circumferences measurements (thigh, upper arm, waist, hip)
Day1
Study Arms (1)
Healthy subjects : Adult and pediatric populations
EXPERIMENTALOnly ultrasound procedures will be performed using an investigational ultrasound system. All subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility assessment and the ultrasound scans will be performed is to evaluate the anatomical characteristics of both anterolateral thighs, one shoulder (deltoid) and one upper arm (biceps and triceps) before and while applying a force similar to the ZENEO® triggering force.
Interventions
Ultrasound scans connected with an application enabling the measurement of the force applied.
Eligibility Criteria
You may qualify if:
- Male or female, 2 to 70 years old, inclusive
- In stable health, as determined by medical history and physical examination at screening (ie, any chronic medical diagnoses or conditions should be stable and well managed, with no significant changes expected during assessments, so that in the opinion of the investigator or designee there will not be any impact on the ability of the subject to participate in the study)
- For the adult population, body mass index (BMI) ≥ 18.5 and ≤ 35 kg/m2 at screening BMI = weight (kg)/(height \[m\])2
- Willing and able to provide written informed consent and assent (as appropriate) prior to initiation of study procedures
- Subjects must be able to communicate effectively with the study staff and to understand study instructions (not applicable for toddlers and preschoolers)
You may not qualify if:
- Any skin or muscular condition, such as eczema, scars, infections, moles, or tattoos at the site of measurements
- Allergy to ultrasound gel
- Any other condition or prior therapy that, in the investigator or designee's opinion, would make the subject unsuitable for the study, or unable or unwilling to comply with the study procedures
- Is an employee or authorized representative of CROSSJECT SA or ICON plc
- Adult under guardianship or subject incarcerated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Crossjectlead
Study Sites (1)
Clinical Trials of Texas, LLC dba Flourish Research
San Antonio, Texas, 78229, United States
Study Officials
- STUDY DIRECTOR
Nathalie LOUGHRAIEB
Crossject
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 28, 2024
Study Start
February 13, 2024
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share